Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
about
APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members.Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.The essential role of evasion from cell death in cancer.Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy.BH3-only proteins in apoptosis at a glanceNeither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs.The BCL-2 protein family, BH3-mimetics and cancer therapy.Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributorDNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and NoxaBCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma.Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in miceHEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy.Transforming growth factor-β directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomas.Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy.A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatmentsRNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model.Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice.Interrogating the relevance of mitochondrial apoptosis for vertebrate development and postnatal tissue homeostasisEvaluation of the BH3-only protein Puma as a direct Bak activatorThe role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy.Deciphering the rules of programmed cell death to improve therapy of cancer and other diseasesA review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.Apoptosis inducers in chronic lymphocytic leukemia.Epstein-Barr virus and Burkitt lymphoma.BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells.Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53.Tumor-Suppressor Functions of the TP53 Pathway.The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B.Low carbohydrate diet prevents Mcl-1-mediated resistance to BH3-mimeticsCoordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.Selective IAP inhibition results in sensitization of unstimulated but not CD40-stimulated chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis.EBV and Apoptosis: The Viral Master Regulator of Cell Fate?p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
P2860
Q33842900-8C838E66-A6BB-49FD-9EB4-D4506A304B6AQ34071295-1F896F06-4C99-4E27-A7CC-04FC72AFB9B3Q34103172-9F94131A-83A1-4F9F-B633-179F86228B43Q34283174-03253065-EC83-494D-AE3B-6A1388744DCFQ35083049-B4CFB709-3705-4440-902E-BE778BB9EA07Q35330220-4C5E18D2-AEDC-47D8-B4DB-5CC1BB1BCCB5Q35740819-C48B7416-91DF-4C30-B0B9-C71A9A64B15CQ35883875-91BA7CC1-4BD7-45E2-95AE-D3B6FEF3030CQ36004204-64160A66-1F1A-4406-8766-9FDEA7C58EAAQ36067778-1E39961D-C874-4083-8E22-A212CD94CC7CQ36347246-DE927A8B-FCCB-4DE7-9CF4-C516D0227842Q36392786-5D3CF4B7-C319-474F-BA37-89D45AF0CAEFQ36472505-3E675FF2-B314-4781-8664-960CF3E70D2CQ36473581-56E247C8-8A01-42D6-A25B-138358920C39Q36535127-04CDA1AF-1F9E-4A7F-8301-BA8B4B1E8216Q36620902-3081E3E4-AC1B-4628-8B50-46198049B455Q36691028-83FC6420-81F6-48C0-B77B-BBFBEDB6B914Q36740744-091712E2-B024-4910-A51C-B0036919E87EQ36797266-A20DC630-EDA7-4363-83C2-4126C19D43E1Q36799279-0E4C9FC9-4B7A-4940-9969-16066EEB2794Q37006778-AC55FD97-4517-49A9-8620-0020FD23A2A0Q37330840-34481435-146B-4051-A044-CEE764CED1A2Q37383229-94FF19F0-E3BC-4CB9-967A-48697C7F9D94Q37428715-03EA8609-02C9-4BC6-BD6B-BB5330E21A01Q37854419-DEDABE34-E94C-466E-9C00-F3BC076B07F1Q37921609-DCFF89C2-9508-4980-93AB-C147EC4173AFQ38061861-F464A482-A33A-4504-A2B9-C469861835B5Q38132359-F8D6ABF2-2EE2-4A4F-B82F-2EDD249829C7Q38187815-3B4FF437-88C4-46D2-9617-2F8EBB244ECBQ38270680-BB8E8F4C-208D-4A50-A32B-7940F1B68099Q38779981-CFDD255A-FEE0-4F1F-8B03-9B167B9B8901Q38809821-BCD4BF3F-F3F7-44B8-9944-6B1DEA67BAFDQ38824332-0DA193A4-2CF4-4472-891E-76C66705A7E4Q39177637-0F9DCAE0-9913-48AF-A255-3F6CD2437B16Q39300586-2C8AB31A-8EE8-49FF-AADB-3D079545A907Q41843138-4438A12B-D3F2-42E7-860D-406DD16AD847Q41928227-FF02EF4E-C0C7-4890-9BBF-0AE3A8A5CBBCQ42930877-20A939BC-4AC1-4A2E-9993-A309EA1BEF1FQ47117102-53A77DA0-49BC-486E-AD41-9DE27EC2C7AFQ49907165-1E490BD3-785C-4F52-90CA-613C63B84FBC
P2860
Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@ast
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@en
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@nl
type
label
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@ast
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@en
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@nl
prefLabel
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@ast
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@en
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@nl
P2093
P2860
P50
P1433
P1476
Maximal killing of lymphoma ce ...... ts Puma and Noxa, but also Bim
@en
P2093
Cassandra J Vandenberg
Clare L Scott
Elisa S Jansen
Ewa M Michalak
Grant Dewson
Jon M Haga
Lina Happo
P2860
P304
P356
10.1182/BLOOD-2010-04-280818
P407
P577
2010-09-09T00:00:00Z